Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30017029HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047835HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047836HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047837HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047838HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS30047839HIVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS20020749HPVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TVIS20020750HPVENSG00000065989.16protein_codingPDE4ANoNo5141P27815
TCGA Plot Options
Drug Information
GenePDE4A
DrugBank IDDB01427
Drug NameAmrinone
Target IDBE0009963
UniProt IDQ08499
Regulation Typeinhibitor
PubMed IDs14577594
CitationsAbdollahi M, Chan TS, Subrahmanyam V, O'Brien PJ: Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to a mitochondrial toxin. Mol Cell Biochem. 2003 Oct;252(1-2):205-11. doi: 10.1023/a:1025568714217.
GroupsApproved
Direct ClassificationBipyridines and oligopyridines
SMILESNC1=CC(=CNC1=O)C1=CC=NC=C1
Pathways
PharmGKBPA164746803
ChEMBLCHEMBL12856